back to top
e-alerts for this Journal

The email alerts service allows anyone who registers their email address to be notified via email when new content goes online.

Recommend this Journal

Recommend this journal to your friend or library.

Submit Manuscript

Manuscripts should be submitted online through our website or as an email attachment to the editorial office at

  • Latest Articles
  • Most Viewed

Latest Articles

Rainbow IMRT and volumetric imaging for anterior mesenteric targets

13 May 2019

A case of a highly mobile mesenteric mass that shifted position daily. It was treated with an intensity modulated radiation the... More

Spine radiosurgery dosimetry — A simple way forward

11 Mar 2019

The investigators behind “Assessing functionality and benefits of comprehensive dose volume prescriptions: An internation... More

Spinal growth patterns after craniospinal irradiation in children with medulloblastoma

04 Feb 2019

The use of electrons to treat the craniospinal axis in children with medulloblastoma resulted in no significant difference in s... More

Brain metastasis growth on preradiosurgical magnetic resonance imaging

06 Dec 2018

Time between pretreatment MRI and SRS is associated with brain metastasis growth, but LC is not compromised when patients recei... More

Liver reirradiation for patients with hepatocellular carcinoma and liver metastasis

10 Nov 2018

Liver reirradiation may be an effective and safe option for select patients; however, further prospective study is necessary to... More

Liver abscess after hepatic stereotactic body radiation therapy

16 Oct 2018

Stereotactic body radiation therapy (SBRT) has emerged as an effective treatment approach because of the ability to focus high ... More

Using synthetic CT for partial brain radiation therapy: Impact on image guidance

08 Sep 2018

DRR synCT geometry was robust. Although statistically significant differences were observed between CT and synCT registrations,... More

Chest wall toxicity after hypofractionated proton beam therapy for liver malignancies

13 Jul 2018

CWT after hypofractionated PBT for liver malignancies is clinically relevant. For a 15-fraction regimen, V47 >20 cm3, V50 &g... More

Intraoperative radiation therapy as part of planned monotherapy for early-stage breast cancer

05 Jun 2018

IORT may be a promising modality, longer follow-up is warranted to better understand exactly which clinicopathological features... More

Cochlea-sparing acoustic neuroma treatment with 4π radiation therapy

07 May 2018

Compared with clinical planning methods, optimized 4π radiation therapy enables statistically significant sparing of the coc... More

Dosimetric comparison of radiation methods for palmar fibrosis

01 Nov 2017

6-MeV electrons with individualized bolus gave superior CTV coverage over superficial radiotherapy at the 90% isodose lines, wi... More

Malignant peripheral nerve sheath tumor: Second or secondary malignancy after Hodgkin’s lym

05 Sep 2016

A patient cured from Hodgkin’s lymphoma (HL) by means of chemotherapy and radiotherapy who developed the mediastinal tumo... More

Most Viewed

Aims And Scope

Journal of Clinical Radiation Oncology (JCRO) is an international refereed journal, which publishes high-quality original articles reporting new information on basic and clinical aspects of Clinical Radiation Oncology. The wide range of topics includes clinical research into any form of radiotherapy, particle radiation therapy, external beam irradiation, brachytherapy, stereotactic radiosurgery/therapy, conformal radiation therapy, and intraoperative radiation therapy, as well as molecular and cellular radiation biology, radiation physics, tumor biology, dosimetry, and radiation treatment planning. The journal encourages submission of manuscripts with relevance to (but not limited to) prospective clinical trials, outcomes research, normal tissue protection (including both precision avoidance and pharmacologic means), and cancer imaging.

Publication of article types

Original research: primary research from any area of Clinical Radiation Oncology, or Clinical Radiation Oncology related/interdisciplinary area.

Case reports: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction.

Editorial: to introduce and comment on major advances and developments in the field.

Methodology: present a new experimental method, test or procedure. The method described may either be completely new, or may offer a better version of an existing method. The article must describe a demonstrable advance on what is currently available. The method needs to have been well tested ideally, but not necessarily, used in a way that proves its value.

News and commentary: short, focused and opinionated articles on any subject with in the journal’s scope. These articles are usually related to a contemporary issue, such as recent research findings, and are often written by opinion of leaders invited by the editorial board. Editorial board members and section editors may write such articles to highlight hot or emerging areas of research within a given field.

Rapid communications: devoted to the publication of short papers presenting highly original and significant material.

Review: to review systematically progress and unresolved problems in the field and make suggestions for future work. Comprehensive, authoritative, descriptions of any subject within the scope of Clinical Radiation Oncology journal.

Short reports: brief reports of data from original research.

Letters to the Editor: to discuss and make reply to the contributions published in JCRO, or to introduce and comment on a controversial issue of general interest.

Publication frequency

All articles of JCRO are posted online immediately as they are ready for publication. All articles will be assigned a DOI number (Digital Object Identifier) where they become searchable and citeable without delay.

Why publish in Journal of Clinical Radiation Oncology ?

  • JCRO offers scientists the opportunity to publish their research rapidly in an open access medium that is freely available online to researchers worldwide.
  • Electronic submission of manuscripts.
  • Immediate publication tentatively within a month/two months of Initial submission.
  • Efficient and objective peer review with a streamlined electronic production workflow.
  • No barriers, which helps your research reach the entire scientific community worldwide.
  • Our professional staff adds further value to your paper through the copy-editing process, which minimize stylistic errors and improves readability.
  • Our professional staff continuously working to improve the search engine rankings for NobleResearch group journals.
  • Our linking program extends too many abstracting and indexing databases, library sites, and includes participation in CrossRefTM.

Peer-review process

Peer-review is commonly accepted as an essential part of scientific publication. We appreciate the time that referees devote to assessing the manuscripts we send them, which helps to ensure that NobleResearch journals publish only material of the highest quality. Peer reviewers are asked to give their opinion on a number of issues pertinent to the scientific and formal aspects of a paper, and to judge the papers on grounds of originality and urgency. All relevant information will be forwarded to the author(s). There are several types of decision possible for each article.

  • Accept manuscript without revision
  • Accept after minor or major revision
  • Submit elsewhere, if the manuscript is better suited for another journal in our group
  • Reject manuscript, if the manuscript is substandard

In addition, papers may be rejected directly by the Chief Editor if judged to be out of scope or if scientifically or formally sub-standard. When asking for revisions, reviewers have two possible goals: to ask authors to tighten their arguments based on existing data, or to identify areas where more data are needed. Even formal revision may be required if the language or formalities is sub-standard. To facilitate rapid publication, authors are given a maximum of two months for revision. After two months, revised manuscripts will be considered as new submissions.


The review process is strictly confidential and should be treated as such by reviewers. Because the author may have chosen to exclude some people from this process, no one not directly involved with the manuscript, including colleagues or other experts in the field, should be consulted by the reviewer unless such consultations have first been discussed with the professional editor.

Timely review

NobleResearch believes that an efficient editorial process that results in timely publication provides a valuable service both to authors and to the scientific community at large. We therefore request that reviewers respond promptly, usually within fourteen (14) days of receipt of a manuscript. If reviewers need more time, we request that they contact us promptly so that we can keep the authors informed and, if necessary, assign alternative reviewers.

Supplemental files

Authors may and should take advantage of the web-based nature of the publication by submitting supplemental files that include animations, software demonstrations and innovative graphics. Supplemental files will be evaluated with the manuscript as part of the peer-review process. They should not exceed 20 megabytes in size. We accept the following file formats for supplemental files: TIF (tif), JPEG (jpg), GIF (gif), Animated GIF (gif), PostScript (ps), Encapsulated PostScript (eps), Adobe Photoshop (psd), AdobePDF (pdf), Audio (au), Audio (mp3), Audio (wav), MPEG (mpg), Quicktime (avi), Quicktime (mov).


You keep the copyright of your article. You are free to print out copies of your article, email it to your colleagues and/or post it on the web. Your colleagues can use and disseminate your work without restriction for educational and scientific purposes.


Journal of Clinical Radiation Oncology offers a wide range of advertising opportunities to promote your product or service. NobleResearch group reserves the right to reject any advertisement not considered suitable for publication.

For more information please contact:

Marketing Director